GCC Nurse Sepsis Bundle Guide

← Back to Index
Critical Care SSC 2018 Bundle Hour-1 Protocol GCC Specific Sepsis-3

Sepsis Hour-1 Bundle & Recognition Guide

Comprehensive clinical reference covering Sepsis-3 definitions, SSC Hour-1 Bundle, source identification, haemodynamic resuscitation, antibiotic stewardship, and GCC-specific sepsis protocols for bedside nursing practice.

SEPSIS IS A MEDICAL EMERGENCY. Every hour of delayed treatment increases mortality by 7%. Activate the sepsis response immediately upon recognition. This guide is for educational reference — always follow your facility's local protocols.
Sepsis-3 Core Definitions (2016)

Infection

Microbial invasion of normally sterile tissue, producing a pathological host response.

Sepsis

Life-threatening organ dysfunction caused by a dysregulated host response to infection. Identified by SOFA score ≥2 from baseline.

Septic Shock

Subset of sepsis with profound circulatory, cellular, and metabolic abnormalities. Requires vasopressors to maintain MAP ≥65 mmHg AND lactate >2 mmol/L despite adequate fluid resuscitation. In-hospital mortality >40%.

What Sepsis-3 Removed

SIRS criteria (temperature, HR, RR, WBC) are no longer part of the adult sepsis definition — they lack sensitivity and specificity. Organ dysfunction is the key discriminator.

SOFA Score — Organ Dysfunction
SystemParameterKey Threshold
RespiratoryPaO₂/FiO₂<400 = score 1+
CoagulationPlatelets (×10³/µL)<150 = score 1+
LiverBilirubin (µmol/L)>20 = score 1+
CardiovascularMAP / vasopressorsMAP <70 = score 1+
CNSGCS<15 = score 1+
RenalCreatinine / urine outputCr >110 µmol/L = 1+

SOFA ≥2 from baseline = organ dysfunction consistent with sepsis. Calculate delta SOFA if baseline known.

qSOFA — Bedside Screening Tool

Quick SOFA for non-ICU settings. Simple 3-point score. Does NOT replace full SOFA — it is a risk stratification tool only.

1. Altered Mentation

GCS <15 or new confusion. Score = 1 point.

2. Respiratory Rate ≥22/min

Tachypnoea as marker of physiologic stress. Score = 1 point.

3. Systolic BP ≤100 mmHg

Hypotension indicating haemodynamic compromise. Score = 1 point.

qSOFA ≥2 = HIGH RISK → Act Now

Perform full SOFA assessment, activate sepsis response team, initiate Hour-1 Bundle evaluation. qSOFA ≥2 associated with >10% in-hospital mortality in non-ICU patients.

NEWS2 — GCC Hospital Alternative Trigger

National Early Warning Score 2 — widely adopted in GCC hospitals as an electronic sepsis trigger within Epic/Cerner systems.

NEWS2 ScoreRisk LevelAction
0–4LowRoutine monitoring q4–6h
5–6MediumUrgent review, consider sepsis screen
≥7HighEMERGENCY — activate sepsis response
3 in single parameterFlagUrgent clinical review

GCC Implementation

Many GCC hospitals have integrated NEWS2 ≥5 or qSOFA ≥2 as automated EMR alerts to trigger the sepsis response team.

Sepsis Mimics — Rule Out First
  • Diabetic Ketoacidosis (DKA) — tachypnoea (Kussmaul), altered mentation, warm vasodilated; check glucose/ketones/ABG
  • Heat Stroke — hyperthermia, CNS dysfunction without infection; common in GCC summer. Core temp >40°C
  • Adrenal Crisis — hypotension unresponsive to fluids; hyponatraemia + hyperkalaemia; cortisol levels
  • Anaphylaxis — rapid onset, urticaria/angioedema, bronchospasm, exposure history
  • Acute Pancreatitis — SIRS criteria met; elevated lipase/amylase; abdominal CT
  • Pulmonary Embolism — hypoxia, tachycardia, pleuritic pain; D-dimer + CTPA
  • Thyroid Storm — extreme tachycardia, hyperthermia, thyroid history
Paediatric Sepsis — SIRS Criteria (Age-Adjusted)

Sepsis-3 does not apply to children <18 years. Use paediatric SIRS + suspected infection + organ dysfunction.

Age GroupHR (beats/min)RR (/min)WBC (×10³)
Neonate (0–7d)>180 or <100>50>34
1 week–1 month>180 or <100>40>19.5 or <5
1 month–1 year>180 or <90>34>17.5 or <5
2–5 years>140>22>15.5 or <6
6–12 years>130>18>13.5 or <4.5
13–18 years>110>14>11 or <4.5

Paediatric septic shock: SBP below 5th percentile for age OR need for vasoactive agent.

Neonatal Sepsis Recognition

Early-Onset Neonatal Sepsis (EOS) — <72 hours

Vertical transmission. Common organisms: GBS (Group B Streptococcus), E.coli, Listeria. Risk factors: prolonged ROM >18h, maternal GBS, prematurity.

Late-Onset Neonatal Sepsis (LOS) — >72 hours

Nosocomial or community. Common: CoNS (NICU), Klebsiella, Pseudomonas, Candida. Risk: central lines, prematurity, prolonged antibiotics.

Neonatal Sepsis Signs (Non-specific)

Temperature instability (hypothermia in preterm) • Lethargy/poor tone • Poor feeding/abdominal distension • Apnoea/tachypnoea • Skin mottling/jaundice • Hypoglycaemia

SSC 2018 Hour-1 Bundle — Complete ALL Within 60 Minutes of Recognition

The Surviving Sepsis Campaign updated the 3-hour and 6-hour bundles to a single Hour-1 Bundle in 2018. Time zero = time of sepsis recognition (not ED arrival). All 5 elements must be completed simultaneously, not sequentially.

1
Measure Lactate (Serum or Arterial)
If lactate >4 mmol/L: begin IV crystalloid 30 ml/kg IMMEDIATELY + ICU admission. If lactate 2–4 mmol/L: assess fluid responsiveness before full bolus. Re-measure lactate at 2 hours if initial >2. Lactate clearance ≥10% in 2h = resuscitation goal.
2
Blood Cultures ×2 Sets BEFORE Antibiotics
Aerobic + anaerobic from 2 separate venepuncture sites (or 1 peripheral + 1 from each central line lumen if already in situ). Volume: 8–10 mL per bottle. Do NOT delay antibiotics >45 minutes for cultures. If unable to obtain rapidly, give antibiotics and note time.
3
Administer Broad-Spectrum Antibiotics
Empirical choice based on suspected source, local antimicrobial guidelines, allergy history, and MDR risk factors. Target to infuse within 1 hour of recognition. Each hour delay in antibiotics increases mortality by 7–10%. See Antibiotic Stewardship tab for empirical choices.
4
IV Crystalloid 30 ml/kg for Hypotension OR Lactate ≥4 mmol/L
Balanced crystalloid preferred (Lactated Ringer's or Hartmann's) over 0.9% saline (excess chloride → hyperchloraemic acidosis). Give over 30–60 min. Reassess after each 500 mL bolus in haemodynamically unstable patients. Document fluid balance hourly.
5
Vasopressors if MAP <65 mmHg after Adequate Fluids
Noradrenaline (norepinephrine) is first-line. Can be started peripherally short-term (≤12h, large bore IV, forearm/antecubital) while central access is obtained. Target MAP ≥65 mmHg. Reassess haemodynamics every 30 minutes during active resuscitation.
Lactate Decision Algorithm

Lactate <2 mmol/L (Normal)

Reassuring. Continue to monitor. Sepsis may still be present — do not rely on lactate alone. Treat other criteria.

Lactate 2–4 mmol/L (Elevated)

Cryptic (occult) hypoperfusion. Assess fluid responsiveness. Give fluids if responsive. Re-measure at 2h. Lactate clearance target ≥10%.

Lactate >4 mmol/L (Critical)

Severe tissue hypoperfusion. 30 ml/kg IV crystalloid IMMEDIATELY. ICU admission. Vasopressors likely needed. Mortality risk >40%.

Note: Lactate elevation may be non-ischaemic (thiamine deficiency, liver disease, metformin, epinephrine). Interpret in clinical context.

Blood Culture Best Practice
  • 2 sets minimum (4 bottles: 2 aerobic + 2 anaerobic) from separate venepuncture sites
  • Volume per bottle: 8–10 mL — underfilling is a common cause of false negatives
  • Skin prep: 70% alcohol + chlorhexidine or povidone-iodine; allow to dry completely (30–60 sec)
  • Do NOT draw from existing peripheral IV lines (contamination risk)
  • Central line suspected as source: draw 1 set peripherally + 1 set per lumen of catheter
  • Label bottles immediately at bedside with time drawn
  • Transport to lab within 2 hours; incubate at 35–37°C
  • Document time drawn vs. time antibiotic given (compliance metric)
Hour-1 Bundle Compliance Tracker
Enter sepsis recognition time, then mark each element complete to track compliance and time-to-completion.
1. Lactate Measured
Serum or arterial lactate drawn and sent to lab
Not yet completed
2. Blood Cultures Drawn (×2 sets)
Aerobic + anaerobic, 2 separate sites, before antibiotics
Not yet completed
3. Broad-Spectrum Antibiotics Administered
IV infusion started — empirical per suspected source
Not yet completed
4. IV Crystalloid 30 ml/kg Started
For hypotension (MAP <65) OR lactate ≥4 mmol/L
Not yet completed
5. Vasopressors Initiated (if MAP <65 after fluids)
Noradrenaline first-line — target MAP ≥65 mmHg. Mark N/A if not required.
Not yet completed
Bundle Compliance 0%
Common Sepsis Sources in GCC Practice
SourceCommon Pathogens (GCC)Clinical CluesKey Investigation
Urinary (UTI/Pyelonephritis)
Most common community		 E.coli (60%), Klebsiella pneumoniae, Proteus, Enterococcus Dysuria, frequency, loin pain, suprapubic tenderness, catheter in situ Urine MC&S (midstream or catheter), urine dipstick, renal USS
Respiratory (CAP/HAP/VAP) S.pneumoniae, H.influenzae (CAP); Pseudomonas, Klebsiella, MRSA (HAP/VAP) Cough, sputum, pleuritic pain, consolidation on CXR, ventilated >48h CXR/CT chest, sputum/BAL MC&S, Legionella + pneumococcal urinary antigen
Abdominal E.coli, Klebsiella, Bacteroides, Enterococcus, mixed flora Abdominal pain/tenderness/guarding, vomiting, jaundice (biliary), elevated LFTs/lipase CT abdomen/pelvis with contrast, abdominal USS, blood cultures ×2, surgical review
Skin/SSTI/Necrotising Fasciitis S.aureus (MRSA), GAS (Strep pyogenes), Vibrio (marine exposure) Cellulitis, wound infection, crepitus (NF), disproportionate pain, diabetes history Wound swab, urgent surgical review, CT soft tissue, blood cultures
Line-Related (CLABSI) CoNS (S.epidermidis), S.aureus/MRSA, Candida, Gram-negatives Fever ± rigors with CVC in situ, line site erythema, no other source found Paired blood cultures (peripheral + central), consider line removal, echocardiography
Endocarditis Streptococci (viridans), S.aureus/MRSA, Enterococcus, HACEK group Murmur, embolic phenomena (Janeway/Osler), IVDU history, prosthetic valve 3 sets blood cultures >6h apart, echocardiography (TOE preferred), Duke criteria
Meningitis/Encephalitis N.meningitidis, S.pneumoniae, Listeria (elderly/immunocompromised), HSV (encephalitis) Headache, neck stiffness, photophobia, rash (meningococcal), altered GCS CT head BEFORE LP (if focal neurology/papilloedema), CSF analysis, blood cultures first
Source Control Timing

Abdominal Source → <12 Hours

Perforated viscus, ischaemic bowel, cholangitis — surgical or interventional radiology drainage within 12 hours of diagnosis. Every hour of delay worsens outcomes.

Remove Infected Hardware

Infected CVC/PICC → remove within 24h (sooner in S.aureus/Candida bacteraemia — 24h). Infected urinary catheter → change. Infected prosthetic device → multidisciplinary decision.

Minimally Invasive Drainage

Abscess, empyema, cholangitis — image-guided percutaneous drainage preferred over open surgery in unstable patients when feasible.

  • Necrotising fasciitis: emergency surgical debridement within hours — do not delay for antibiotic response
  • Ascending cholangitis: ERCP or percutaneous biliary drainage within 12h
  • Pyonephrosis: nephrostomy drainage; ureteric stent as alternative
  • Retained obstetric products: uterine evacuation
Imaging Priority in Undifferentiated Sepsis
1
Bedside CXR — immediate, portable, non-invasive. Rules out consolidation, effusion, pneumothorax. Available within 30 min.
2
Bedside POCUS (USS) — cardiac (effusion, function), lung (B-lines, consolidation), abdominal (free fluid, biliary, renal). Rapid, no radiation.
3
CT Chest/Abdomen/Pelvis with contrast — gold standard for occult abdominal/pelvic source. Ensure renal function acceptable. IV contrast risk vs. benefit.
4
MRI — for CNS source (encephalitis, cerebral abscess), spinal epidural abscess (back pain + sepsis), osteomyelitis.

Do Not Delay Antibiotics for Imaging

If patient deteriorating: draw cultures → give antibiotics → then imaging. Time to antibiotics takes precedence over complete source localisation.

Procalcitonin (PCT) for Antibiotic De-escalation

PCT <0.25 ng/mL

Bacterial infection unlikely. Consider antibiotic discontinuation (in context). Strong argument against prolonged antibiotics.

PCT 0.25–0.5 ng/mL

Grey zone. Clinical correlation essential. Consider de-escalation if downtrending consistently.

PCT >0.5 ng/mL

Bacterial infection probable. Continue antibiotics. Re-measure every 48–72h.

PCT-Guided De-escalation Strategy

Declining PCT by ≥80% from peak OR PCT <0.5 ng/mL + clinical improvement (afebrile, haemodynamically stable, tolerating oral) → consider antibiotic de-escalation or stop. PCT guidance reduces antibiotic duration by 1–2 days without increasing mortality (PRORATA, SAPS trials).

Fluid Responsiveness Assessment

Pulse Pressure Variation (PPV) / Stroke Volume Variation (SVV)

For mechanically ventilated patients in sinus rhythm. PPV or SVV >13% = fluid responsive. Requires tidal volume ≥8 ml/kg IBW. Not valid in arrhythmias, spontaneous breathing, or ARDS low-volume ventilation.

Passive Leg Raise (PLR) Test

For spontaneously breathing patients. Elevate legs to 45° (supine) for 1 minute → 300 mL "autotransfusion". CO increase ≥10% by POCUS or pulse contour = fluid responsive. Immediately reversible — safe in fluid overload risk.

Mini Fluid Challenge

250–500 mL crystalloid over 10–15 min. Assess cardiac output response. Avoids large fluid boluses in uncertain fluid status. Preferred in patients with pulmonary oedema risk.

Static Predictors — Poor Reliability

CVP, PCWP, IVC diameter alone are unreliable indicators of fluid responsiveness. Dynamic measures (PPV, PLR, mini-challenge) are preferred per SSC guidelines.

Fluid Balance Targets in Sepsis

Hour 1–6 (Early Resuscitation)

Aggressive fluid resuscitation appropriate — 30 ml/kg if indicated. Target MAP ≥65, UO ≥0.5 ml/kg/h, lactate clearance ≥10%.

Day 2–3 (ICU — Fluid Conservative Phase)

Avoid ongoing positive fluid balance. FACTT, CLASSIC trials show negative/neutral balance from Day 2 associated with shorter ventilation, less AKI. Target slightly negative or neutral balance.

Fluid Overload — Harms

Cumulative positive fluid balance >10% body weight associated with: pulmonary oedema, prolonged ventilation, ileus, abdominal compartment syndrome, AKI worsening, increased mortality.

  • Monitor fluid balance hourly in unstable septic shock
  • Daily weights in ICU patients
  • Consider early diuresis once haemodynamically stable (Day 2–3)
  • Albumin 4% may be considered if large volumes of crystalloid required (>3L), per SSC guidance
Vasopressor Titration Guide
AgentDose RangeRole in SepsisKey Considerations
Noradrenaline (Norepinephrine)
FIRST-LINE		 0.01–3 mcg/kg/min Alpha-1 (vasoconstriction) + mild beta-1. Raises SVR + MAP. Preferred vasopressor in septic shock. Central line preferred; short-term peripheral large-bore acceptable. Monitor for digital ischaemia at high doses.
Vasopressin
SECOND-LINE		 0.03–0.04 U/min (fixed) V1 receptor — splanchnic vasoconstriction. Spares noradrenaline dose. Added when noradrenaline ≥0.25 mcg/kg/min. Do NOT titrate vasopressin — use fixed dose. Can reduce noradrenaline requirements (VASST trial).
Adrenaline (Epinephrine)
CARDIAC SUPPORT		 0.01–1 mcg/kg/min Strong beta-1 inotrope + alpha-1. For septic cardiomyopathy with low CO despite noradrenaline. Raises lactate (metabolic effect, not ischaemia) — do not use lactate clearance as target if adrenaline running. Tachycardia risk.
Dobutamine
INOTROPE		 2–20 mcg/kg/min Beta-1 inotrope for septic cardiomyopathy (EF <40%, low CO). Add to noradrenaline; do not use alone in vasodilatory shock. Can cause hypotension (beta-2 vasodilation) and tachycardia. Titrate cautiously.
Resuscitation Endpoints
ParameterTarget
MAP≥65 mmHg (higher 70–75 in chronic hypertension)
Urine Output≥0.5 mL/kg/h (not reliable alone)
Lactate Clearance≥10% reduction in 2 hours from baseline
ScvO₂ (central venous)≥70% (SvO₂ mixed ≥65%)
Capillary Refill Time≤2 seconds (peripheral perfusion marker)
Mottling ScoreReducing mottling (knee mottling ≤Score 2)

EGDT is Outdated

ProCESS, ARISE, ProMISe trials showed protocolised EGDT (CVP 8–12, ScvO₂-driven) is NOT superior to usual care. Use clinical gestalt + lactate + MAP + urine output instead.

Additional Supportive Interventions
  • Corticosteroids: Hydrocortisone 200 mg/day IV (50 mg q6h or infusion) if noradrenaline >0.25 mcg/kg/min AND adequate fluids fail to stabilise. ADRENAL trial: reduces vasopressor duration. Do NOT use if shock resolving.
  • Glucose control: Target blood glucose 6–10 mmol/L (110–180 mg/dL). Avoid hypoglycaemia. Use insulin infusion if persistent >10 mmol/L in ICU.
  • Red cell transfusion: Hb threshold 7 g/dL in stable sepsis (TRISS trial). Higher threshold 9 g/dL in myocardial ischaemia or haemorrhage.
  • VTE prophylaxis: LMWH (enoxaparin) unless contraindicated. Sepsis = high VTE risk. Mechanical compression if anticoagulation contraindicated.
  • Stress ulcer prophylaxis: Proton pump inhibitor IV/PO in mechanically ventilated patients or high GI bleed risk.
  • Renal replacement therapy: Initiate for refractory hyperkalaemia, severe acidaemia (pH <7.15), or oliguria unresponsive to treatment.
qSOFA + NEWS2 Combined Risk Screener

qSOFA Criteria (1 point each)

NEWS2 Triggers (select if present)

Empirical Antibiotic Choices by Suspected Source

Always check local antibiogram data, patient allergy history, and recent culture results before prescribing. These are general GCC-region empirical recommendations.

Suspected SourceFirst-Line EmpiricalAlternative / MDR RiskDuration
Community Pneumonia (CAP) Amoxicillin-clavulanate + Azithromycin
OR Ceftriaxone 1–2g + Azithromycin		 Levofloxacin monotherapy (if no fluoroquinolone use in past 3 months) 5–7 days
Hospital-Acquired Pneumonia (HAP) Piperacillin-tazobactam 4.5g q6h Meropenem 1g q8h if ESBL risk/prior antibiotics; add vancomycin if MRSA risk 7–8 days
VAP (Ventilator-Associated) Piperacillin-tazobactam + Amikacin Meropenem ± colistin if CRE/Acinetobacter; vancomycin/linezolid for MRSA 7–8 days (not longer)
Urinary Sepsis (urosepsis) Ceftriaxone 1–2g IV q24h
OR Gentamicin 5 mg/kg IV once daily		 Meropenem if prior ESBL, healthcare exposure, or failure to respond at 48h 7 days (uncomplicated); 14 days (bacteraemia)
Abdominal Sepsis Piperacillin-tazobactam 4.5g q6h Meropenem + Metronidazole if MDR risk or prior pip-tazo; add vancomycin for enterococcal risk (post-liver transplant) 4–7 days after source control
CLABSI / Line Infection Vancomycin 25–30 mg/kg load then q8–12h (adjust AUC-guided) + Pip-tazo Daptomycin (if VRE or Vancomycin intolerance); add antifungal if Candida risk (TPN, broad-spectrum >7d, ICU >7d) 14 days (S.aureus minimum); 7 days (CoNS after line removal)
Immunocompromised (neutropaenia/transplant) Meropenem 1g q8h + Vancomycin Add antifungal (micafungin or voriconazole) if febrile neutropaenia >4 days on antibiotics; consider Tazocin + aminoglycoside initially Until neutrophil recovery + afebrile 48h
Antibiotic De-escalation Protocol
1
Review at 48–72 hours with preliminary culture sensitivities. Narrow spectrum if organism identified. Switch from combination to monotherapy if appropriate.
2
IV to Oral Switch when: tolerating oral medications, afebrile >24h, haemodynamically stable, GI tract functioning. Oral bioavailability of fluoroquinolones, metronidazole, linezolid = near 100%.
3
Antibiotic Duration: Most sepsis sources: 5–7 days with clinical improvement. Prolonged courses for endocarditis (4–6 weeks), osteomyelitis (6 weeks), cerebral abscess (4–6 weeks).
4
PCT-Guided Stopping: PCT declining ≥80% from peak + clinical improvement → consider stopping at Day 5–7 even before "typical" duration complete.

Benefits of De-escalation

Reduces C.difficile risk • Reduces ESBL/CRE selection pressure • Decreases drug costs • Reduces adverse effects (nephrotoxicity, hepatotoxicity). De-escalation does NOT increase mortality (MERINO, RANDOMIzE-ABX trials).

MDR Organism Considerations in GCC

ESBL-Producing Enterobacteriaceae

Prevalent in GCC due to high antibiotic use and healthcare exposure. E.coli + Klebsiella ESBL require carbapenem therapy. Screen: prior antibiotics, recurrent UTI, healthcare contact, travel to India/Pakistan.

Carbapenem-Resistant Enterobacteriaceae (CRE)

NDM-producing K.pneumoniae/E.coli common. Limited treatment options: ceftazidime-avibactam, meropenem-vaborbactam, colistin (last resort). Contact Infectious Diseases immediately.

Hypervirulent K.pneumoniae (HvKP)

Emerging in UAE/Saudi Arabia. Causes primary liver abscess + septicaemia ± endophthalmitis in diabetic patients. Hypermucoviscous phenotype. Often susceptible to standard antibiotics but aggressive clinical course.

Community-Acquired MRSA (CA-MRSA)

Growing prevalence in GCC. Associated with skin/soft tissue infections, necrotising pneumonia. Empirically cover in severe CAP + young healthy patients with necrotising features.

Vancomycin Monitoring — GCC Practice

AUC-Guided Dosing (Preferred)

Target AUC/MIC 400–600 mg·h/L. Use Bayesian software (e.g., InsightRx). Reduces nephrotoxicity vs. trough-only dosing.

Traditional Trough Monitoring

Trough 15–20 mg/L for serious infections. If unavailable, trough target 10–15 mg/L for less severe. Check trough before 4th dose.

Nephrotoxicity Monitoring

Check SCr daily in ICU. Co-administration with pip-tazo significantly increases nephrotoxicity risk (ACORN trial). Consider alternative in high-risk patients.

Sepsis Epidemiology in GCC
MetricGCC DataGlobal Comparison
In-hospital mortality (sepsis)30–40%25–30% globally
ICU sepsis prevalence~25–30% of ICU admissions~20–30% globally
Most common community sourceUrinary (40–50%)Urinary / respiratory
Mean age at presentationYounger than Western (diabetes, expat workers)Older populations (Europe/US)
MRSA prevalence in GCC20–35% of S.aureus isolates15–30% globally
ESBL prevalence (E.coli)30–50% in some GCC hospitals10–30% globally
GCC-Specific Pathogens & Patterns
  • Hypervirulent K.pneumoniae (HvKP): UAE, Saudi Arabia, Kuwait — liver abscess + metastatic infection in T2DM. High clinical vigilance needed. CT liver if K.pneumoniae bacteraemia in diabetic.
  • MDR Gram-negatives: ESBL/CRE high due to over-the-counter antibiotic use (unregulated in some GCC areas), high volume international travel, and medical tourism.
  • Brucellosis presenting as sepsis: Animal exposure, raw milk/unpasteurised dairy common in rural GCC. Brucella can mimic sepsis — check exposure history + serology.
  • Salmonella typhi: Common in expat workers from South Asia. Blood cultures positive in 70–80% of typhoid fever. Ciprofloxacin-resistant strains increasing.
  • Heat-related illness: Exertional heat stroke in outdoor workers (construction, landscaping) can trigger SIRS and multi-organ failure — exclude infection before labelling as sepsis.
  • MERS-CoV: Zoonotic coronavirus (dromedary camels) — Saudi Arabia primarily. Severe respiratory sepsis/ARDS. PPE essential. Report to public health.
Electronic Sepsis Alerts in GCC EMR

Sepsis-3 EMR Triggers

Leading GCC hospitals (Cleveland Clinic Abu Dhabi, Hamad Medical Corporation, KFSHRC) have implemented automated Sepsis-3 alerts in Epic/Cerner when SOFA ≥2 + suspected infection + abnormal vitals converge.

Alert Response Protocol

1. Nurse assesses at bedside immediately. 2. Inform charge nurse + attending/resident. 3. Initiate sepsis documentation. 4. Begin Hour-1 Bundle elements. 5. Consider Rapid Response Team activation.

Alert Fatigue Challenge

High false-positive rate (60–80%) for automated sepsis alerts. Critical thinking essential — not every alert = sepsis. Clinical gestalt + tools like qSOFA aid appropriate response.

  • Document sepsis screening result (positive/negative) with reasoning in EMR
  • If screening negative, document reason for not activating bundle
  • Time-stamp all bundle elements for compliance reporting
Sepsis Nurse Specialist & Team Roles

Sepsis 6 Champion (Emerging GCC Role)

Adapted from UK Sepsis Trust model. Dedicated nurse responsible for: sepsis education, bundle compliance auditing, mortality review, staff training, policy development. KFSHRC, HMC piloting this model.

  • Bedside Nurse: First to recognise — activate response, draw cultures, start fluids, document timeline
  • Charge Nurse: Escalation, resource mobilisation, emergency bed management
  • Rapid Response Team (RRT): Advanced assessment, ICU triage, invasive access, vasopressors initiation
  • Intensivist: ICU admission decision, advanced haemodynamic management, source control coordination
  • Pharmacist: Antibiotic selection, dose optimisation, allergy reconciliation, de-escalation recommendations
  • Infectious Diseases: MDR organism guidance, antibiotic stewardship, unusual pathogens
  • Microbiologist: Culture result interpretation, sensitivity reporting, outbreak surveillance
Family Communication in Sepsis

Prognosis Communication

Be honest: septic shock carries >40% in-hospital mortality. Use clear language. Avoid medical jargon. "The infection has caused several organs to start struggling" is more understood than "multi-organ dysfunction syndrome."

Organ Failure Explanation

Explain each failing organ system: kidney (oliguria, creatinine rising), lung (ventilator), heart (vasopressors), liver (jaundice, coagulopathy). Use visual aids/diagrams when available in local language.

Goals of Care Discussion

Initiate early: "We are treating aggressively. We also want to understand what matters most to your family member." Explore: resuscitation preferences, ICU escalation limits, dignity in care, cultural/religious wishes.

  • Use professional interpreter (not family member) for non-English/Arabic speakers — critical in GCC with diverse expat population
  • Document family meetings in EMR with attendees, content, and decisions
  • Involve hospital chaplain, patient relations, ethics team early in prolonged sepsis
  • Daily family updates — even brief — significantly reduce family distress and PTSD
  • Provide written information (sepsis fact sheets) in Arabic, English, Urdu, Malayalam — available from World Sepsis Day resources
Sepsis Awareness & Quality Initiatives in GCC

World Sepsis Day — Sept 13

Global awareness campaign. GCC hospitals participate with public education, staff CME, social media campaigns. Organised by Global Sepsis Alliance (GSA). Theme changes annually.

Surviving Sepsis Campaign GCC Chapter

SSC has regional engagement in GCC. SCCM, ESICM global guidelines applied locally with modifications for GCC epidemiology (MDR organisms, resource variation, cultural considerations).

Quality Metrics Tracked in GCC

Hour-1 Bundle compliance rate • Time to first antibiotic • Blood culture positive rate before antibiotics • ICU sepsis mortality rate • Sepsis readmission at 30 days

Practice MCQs — Sepsis Bundle Knowledge Check

Score: 0 / 10
0/10